Wednesday, 2 December 2020

South Korea Daewoong Pharma Eyes Phase II Trials Of Coronavirus Drug, Shares Jump

South Korean drugmaker Daewoong Pharma said on Thursday it had sought regulatory approval for Phase II trials of its antiparasite niclosamide drug to treat COVID19 patients, sending its shares up nearly 6%.

from Top Business News- News18.com https://ift.tt/37yA5Is
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Beyond Borders: The True Origins Of India's Favorite Brands - Colgate, Bata And Maruti

Bata grew into one of the world's leading shoemakers, with an impressive annual sale of 150 million pairs of shoes across more than 70 c...